SEC62 and neoplasm: However, many of the upper mentioned results were obtained using a transient siRNA based SEC62 knockdown, which is no option for a therapeutic approach in humans and cannot be used to evaluate the role of SEC62 expression level on tumor growth and metastasis as well as potential therapeutic interventions in vivo.